ChIP analysis revealed that Sp1 binding to the prkcb promoter was significantly upregulated in PKCα-KR transduced CLL-like cells at all three Sp1 binding sites, compared with MIEV cells (Figure 2B). Here, PRKCB is linked to B-cell chronic lymphocytic leukemia.